BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 30119695)

  • 1. p53 activation: a checkpoint for precision genome editing?
    Conti A; Di Micco R
    Genome Med; 2018 Aug; 10(1):66. PubMed ID: 30119695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoring the p53 'Guardian' Phenotype in p53-Deficient Tumor Cells with CRISPR/Cas9.
    Chira S; Gulei D; Hajitou A; Berindan-Neagoe I
    Trends Biotechnol; 2018 Jul; 36(7):653-660. PubMed ID: 29478674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A CRISPR/CAS9-based strategy targets the personalized chimeric neosequence in fusion-driven cancer genome for precision medicine.
    Huang W; Zeng ZC; Wang WT; Sun YM; Chen YQ; Luo XQ; Fang K
    Clin Transl Med; 2021 Mar; 11(3):e355. PubMed ID: 33783997
    [No Abstract]   [Full Text] [Related]  

  • 4. Mammalian synthetic biology in the age of genome editing and personalized medicine.
    Ho P; Chen YY
    Curr Opin Chem Biol; 2017 Oct; 40():57-64. PubMed ID: 28628856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of genome editing tools in precision medicine research.
    Li S; Yang YY; Qiu Y; Chen Y; Xu LW; Ding QR
    Yi Chuan; 2017 Mar; 39(3):177-188. PubMed ID: 28420614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surprising CRISPR roadblocks.
    Rusk N
    Nat Methods; 2018 Aug; 15(8):569. PubMed ID: 30065373
    [No Abstract]   [Full Text] [Related]  

  • 7. The CRISPR-Cas app goes viral.
    Lemay ML; Horvath P; Moineau S
    Curr Opin Microbiol; 2017 Jun; 37():103-109. PubMed ID: 28623719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR-Cas13a system: a novel approach to precision oncology.
    Zhang J; You Y
    Cancer Biol Med; 2020 Feb; 17(1):6-8. PubMed ID: 32296572
    [No Abstract]   [Full Text] [Related]  

  • 9. Reversal of tumor malignization and modulation of cell behaviors through genome editing mediated by a multi-functional nanovector.
    Liu BY; He XY; Zhuo RX; Cheng SX
    Nanoscale; 2018 Dec; 10(45):21209-21218. PubMed ID: 30417194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assembly of CRISPR ribonucleoproteins with biotinylated oligonucleotides via an RNA aptamer for precise gene editing.
    Carlson-Stevermer J; Abdeen AA; Kohlenberg L; Goedland M; Molugu K; Lou M; Saha K
    Nat Commun; 2017 Nov; 8(1):1711. PubMed ID: 29167458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas9 and p53: An Odd Couple Requiring Relationship Management.
    Ylä-Herttuala S
    Mol Ther; 2018 Dec; 26(12):2711. PubMed ID: 30454954
    [No Abstract]   [Full Text] [Related]  

  • 12. A CRISPR/dCasX-mediated transcriptional programming system for inhibiting the progression of bladder cancer cells by repressing c-MYC or activating TP53.
    Cao C; Yao L; Li A; Zhang Q; Zhang Z; Wang X; Gan Y; Liu Y; Zhang Q
    Clin Transl Med; 2021 Sep; 11(9):e537. PubMed ID: 34586743
    [No Abstract]   [Full Text] [Related]  

  • 13. Methods for In Vivo CRISPR/Cas Editing of the Adult Murine Retina.
    Hung SS; Li F; Wang JH; King AE; Bui BV; Liu GS; Hewitt AW
    Methods Mol Biol; 2018; 1715():113-133. PubMed ID: 29188510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harnessing the native type I-B CRISPR-Cas for genome editing in a polyploid archaeon.
    Cheng F; Gong L; Zhao D; Yang H; Zhou J; Li M; Xiang H
    J Genet Genomics; 2017 Nov; 44(11):541-548. PubMed ID: 29169919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted Gene Manipulation in Plants Using the CRISPR/Cas Technology.
    Zhang D; Li Z; Li JF
    J Genet Genomics; 2016 May; 43(5):251-62. PubMed ID: 27165865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hope, despair and CRISPR - the race to save one woman's life.
    Ledford H
    Nature; 2024 Jun; 630(8016):284-288. PubMed ID: 38867133
    [No Abstract]   [Full Text] [Related]  

  • 17. CRISPR cures and cancer vaccines: researchers can help to shepherd them to market.
    Nature; 2024 Jun; 630(8016):269. PubMed ID: 38867131
    [No Abstract]   [Full Text] [Related]  

  • 18. Researchers Use Plasmid Gene Editing to Personalize Solid Tumor T-Cell Therapy.
    Larkin H
    JAMA; 2022 Dec; 328(22):2201-2202. PubMed ID: 36511936
    [No Abstract]   [Full Text] [Related]  

  • 19. The CRISPR/Cas9 Genome Editing Revolution.
    Jiao R; Gao C
    J Genet Genomics; 2016 May; 43(5):227-8. PubMed ID: 27256542
    [No Abstract]   [Full Text] [Related]  

  • 20. Progress of CRISPR-Cas Based Genome Editing in Photosynthetic Microbes.
    Naduthodi MIS; Barbosa MJ; van der Oost J
    Biotechnol J; 2018 Sep; 13(9):e1700591. PubMed ID: 29396999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.